BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 37524533)

  • 21. Long-term toxic effects of proton radiotherapy for paediatric medulloblastoma: a phase 2 single-arm study.
    Yock TI; Yeap BY; Ebb DH; Weyman E; Eaton BR; Sherry NA; Jones RM; MacDonald SM; Pulsifer MB; Lavally B; Abrams AN; Huang MS; Marcus KJ; Tarbell NJ
    Lancet Oncol; 2016 Mar; 17(3):287-298. PubMed ID: 26830377
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Local control in non-metastatic medulloblastoma.
    Christopherson KM; Bradley JA; Rotondo RL; Pincus DW; Fort JA; Morris CG; Mendenhall NP; Marcus RB; Indelicato DJ
    Acta Oncol; 2014 Sep; 53(9):1151-7. PubMed ID: 24991891
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Long-term outcomes of adult medulloblastoma patients treated with radiotherapy.
    De B; Beal K; De Braganca KC; Souweidane MM; Dunkel IJ; Khakoo Y; Gilheeney SW; DeAngelis LM; Menzel P; Patel SH; Wolden SL
    J Neurooncol; 2018 Jan; 136(1):95-104. PubMed ID: 29019042
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prognostic value of Ki-67 index in adult medulloblastoma after accounting for molecular subgroup: a retrospective clinical and molecular analysis.
    Zhao F; Zhang J; Li P; Zhou Q; Zhang S; Zhao C; Wang B; Yang Z; Li C; Liu P
    J Neurooncol; 2018 Sep; 139(2):333-340. PubMed ID: 29687281
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Adult medulloblastoma: an analysis of survival and prognostic factors.
    Le QT; Weil MD; Wara WM; Lamborn KR; Prados MD; Edwards MS; Gutin PH
    Cancer J Sci Am; 1997; 3(4):238-45. PubMed ID: 9263630
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The clinical treatment and outcome of cerebellopontine angle medulloblastoma: a retrospective study of 15 cases.
    Wu T; Qu PR; Zhang S; Li SW; Zhang J; Wang B; Liu P; Li CD; Zhao F
    Sci Rep; 2020 Jun; 10(1):9769. PubMed ID: 32555264
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Outcome and prognostic factors of radiation therapy for medulloblastoma.
    Rieken S; Mohr A; Habermehl D; Welzel T; Lindel K; Witt O; Kulozik AE; Wick W; Debus J; Combs SE
    Int J Radiat Oncol Biol Phys; 2011 Nov; 81(3):e7-e13. PubMed ID: 21345611
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prolongation of radiotherapy duration is associated with inferior overall survival in patients with pediatric medulloblastoma and central nervous system primitive neuroectodermal tumors.
    Baliga S; Bajaj BVM; Kabarriti R; Grassberger C; Patteson B; Yeap B; Fox JL; Garg MK; Yock TI
    Pediatr Blood Cancer; 2020 Oct; 67(10):e28558. PubMed ID: 32710698
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Craniospinal radiotherapy in combined therapy of medulloblastoma in children and adolescents].
    Golubicić I; Bokun J; Nikitović M; Mladenović J; Sarić M; Bekić Z
    Srp Arh Celok Lek; 2003; 131(5-6):226-31. PubMed ID: 14692129
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Medulloblastoma--a retrospective analysis.
    Awasthy BS; Das Gupta C; Singh R; Patel AK; Julka PK
    Indian J Pediatr; 1997; 64(5):693-7. PubMed ID: 10771904
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A Multi-institutional Comparative Analysis of Proton and Photon Therapy-Induced Hematologic Toxicity in Patients With Medulloblastoma.
    Liu KX; Ioakeim-Ioannidou M; Susko MS; Rao AD; Yeap BY; Snijders AM; Ladra MM; Vogel J; Zaslowe-Dude C; Marcus KJ; Yock TI; Grassberger C; Braunstein SE; Haas-Kogan DA; Terezakis SA; MacDonald SM
    Int J Radiat Oncol Biol Phys; 2021 Mar; 109(3):726-735. PubMed ID: 33243479
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical characteristics and abandonment and outcome of treatment in 67 Chinese children with medulloblastoma.
    Wang C; Yuan XJ; Jiang MW; Wang LF
    J Neurosurg Pediatr; 2016 Jan; 17(1):49-56. PubMed ID: 26451721
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Efficacy of Carboplatin and Isotretinoin in Children With High-risk Medulloblastoma: A Randomized Clinical Trial From the Children's Oncology Group.
    Leary SES; Packer RJ; Li Y; Billups CA; Smith KS; Jaju A; Heier L; Burger P; Walsh K; Han Y; Embry L; Hadley J; Kumar R; Michalski J; Hwang E; Gajjar A; Pollack IF; Fouladi M; Northcott PA; Olson JM
    JAMA Oncol; 2021 Sep; 7(9):1313-1321. PubMed ID: 34292305
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Medulloblastoma in Older Adults: A Case Report and Literature Review.
    Murase M; Saito K; Abiko T; Yoshida K; Tomita H
    World Neurosurg; 2018 Sep; 117():25-31. PubMed ID: 29883827
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Outcomes of salvage re-irradiation in recurrent medulloblastoma correlate with age at initial diagnosis, primary risk-stratification, and molecular subgrouping.
    Gupta T; Maitre M; Sastri GJ; Krishnatry R; Shirsat N; Epari S; Sahay A; Chinnaswamy G; Patil V; Shetty P; Moiyadi A
    J Neurooncol; 2019 Sep; 144(2):283-291. PubMed ID: 31236820
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Molecular subgrouping and characterization analysis of medulloblastomas in a cohort of Japanese patients].
    Wataya T; Hamasaki M; Taylor MD
    No Shinkei Geka; 2015 Feb; 43(2):117-25. PubMed ID: 25672552
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Medulloblastoma: clinicopathological correlates of SHH, WNT, and non-SHH/WNT molecular subgroups.
    Ellison DW; Dalton J; Kocak M; Nicholson SL; Fraga C; Neale G; Kenney AM; Brat DJ; Perry A; Yong WH; Taylor RE; Bailey S; Clifford SC; Gilbertson RJ
    Acta Neuropathol; 2011 Mar; 121(3):381-96. PubMed ID: 21267586
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Molecular subgroups of medulloblastoma: an international meta-analysis of transcriptome, genetic aberrations, and clinical data of WNT, SHH, Group 3, and Group 4 medulloblastomas.
    Kool M; Korshunov A; Remke M; Jones DT; Schlanstein M; Northcott PA; Cho YJ; Koster J; Schouten-van Meeteren A; van Vuurden D; Clifford SC; Pietsch T; von Bueren AO; Rutkowski S; McCabe M; Collins VP; Bäcklund ML; Haberler C; Bourdeaut F; Delattre O; Doz F; Ellison DW; Gilbertson RJ; Pomeroy SL; Taylor MD; Lichter P; Pfister SM
    Acta Neuropathol; 2012 Apr; 123(4):473-84. PubMed ID: 22358457
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Medulloblastoma of the adult: results from a multicenter retrospective study by AINO (Italian Association of Neuro-Oncology) and SIN (Italian Society of Neurology).
    Gaviani P; Simonetti G; Rudà R; Franchino F; Lombardi G; Possanzini M; Squintu S; Villani V; Teriaca M; Cavallieri F; Caffo M; Salmaggi A; Bianco A; Anghileri E; Farinotti M; Tramacere I; Silvani A
    Neurol Sci; 2021 Feb; 42(2):665-671. PubMed ID: 32654010
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Extraneural metastases of medulloblastoma: desmoplastic variants may have prolonged survival.
    Young RJ; Khakoo Y; Yhu S; Wolden S; De Braganca KC; Gilheeney SW; Dunkel IJ
    Pediatr Blood Cancer; 2015 Apr; 62(4):611-5. PubMed ID: 25504865
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.